The great explorer of the truth, the master-builder of human happiness no one rejects dislikes avoids pleasure itself because it is pleasure but because know who do not those how to pursue pleasures rationally encounter consequences that are extremely painful desires to obtain.Read More
North America Gene Editing Market Share to Amass USD 3.6 Bn By 2026
Published Date: 2020-11-11
Request a sample
According to the Graphical Research new growth forecast report titled North America Gene Editing Market value is set to exceed USD 3.6 billion by 2026. Growing R&D expenditures by pharmaceutical, biopharmaceutical companies as well as research institutes has positively impacted the market growth and will continue to drive the industry progression over the analysis period. Recent developments have added innovations in the gene editing techniques. Currently utilized gene editing technique is highly efficient and possess commendable accuracy as compared to the conventional gene editing techniques available. North America based biotechnology industries have raised their R&D operations and expenditures in the countries such as the U.S. and Canada enabling them to make advanced gene editing techniques available at a lower cost thereby, propelling the industry growth.
Based on application, the North America gene editing market is fragmented into cell line engineering, animal genetic engineering, plant genetic engineering and other applications. The animal genetic engineering segment witnessed around 27% market share in 2019 and is projected to get nearly triple in terms of market value in 2026. Genetically engineered animals show increased resistance, productivity, feed efficiency, and improved overall health. They also provide better yields of meat, eggs and milk. Additionally, growing consumption of dairy as well as other commercial products obtained from domestic animals has encouraged the demand for gene editing techniques, thereby propelling the market growth.
The gene editing market, based on technology, is classified into TALENs, Zinc Finger Nucleases (ZFNs), CRISPR/Cas9, and others. The CRISPR/Cas9 segment is estimated to account for around USD 683 million in 2019 and is anticipated to grow at highest CAGR over the analysis period, among all other technologies. CRISPR technology is easy to use, simple, and inexpensive unlike the other gene editing techniques such as TALENs, thereby, increasing its adoption rate. Moreover, growing demand for CRISPR/Cas9 in altering the genome of organisms, complex or simple, to develop commercially feasible products will boost the market growth.
Based on end-user, the industry is segmented into research institutes, contract research organizations (CROs), and biotech and pharma companies. The research institutes accounted for significant market share in 2019 and is expected to grow at around 15% CAGR over the projected timeframe. Higher demand for innovations in therapeutic disciplines to treat various genetic disorders will pave the way for lucrative segmental growth. Additionally, increasing government grants and support for research studies undertaken by scientists have significantly propelled the segmental growth.
Canada gene editing market is projected to witness nearly 14% CAGR over the analysis timeframe. Plant breeders in Canada are increasingly turning to genome-edited applications in the development of new varieties. Also, growing support from government to fund gene editing-based research studies for genetic disorders in Canada will further favor the industry growth. However, Canadian government has set some strict rules and regulations pertaining to the use of genome editing tools in humans that will limit the market growth in the country to some extent.
Some of the leading market players operating in North America gene editing market include Agilent Technologies, Origene Technologies, Integrated DNA Technologies, Thermo Fisher Scientific, Takara Bio, Sangamo Therapeutics, Origene Technologies, EMD Millipore (Merck KGAa), Caribou Biosciences and others. These industry participants are undertaking several initiatives to deliver new and innovative aspects of gene editing techniques that should bolster them to garner major chunk of the market share. For instance, in July 2020, Editas Medicine made partnership with Catelent for supporting gene editing medicine pipeline. This strategy will help the company in expanding its product portfolio.
North America gene editing market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2015 to 2026, for the following segments:
Market Share, By Application, 2015 - 2026 (USD Million)
- Cell line engineering
- Animal genetic engineering
- Plant genetic engineering
Market Size, By Technology, 2015 - 2026 (USD Million)
- Zinc Finger Nucleases (ZFNs)
Market Trends, By End-user, 2015 - 2026 (USD Million)
- Biotech and pharma companies
- Contract Research Organizations (CROs)
- Research institutes
The above information is provided for the following region and countries:
- North America